Article Text
Statistics from Altmetric.com
Footnotes
Contributors OCM drafted and revised the manuscript. SDN revised the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests SDN participated in scientific advisory boards for Biogen, Genentech, Celgene, EMD Serono, is an advisor for Gerson Lehrman Group and a clinical adjudication committee member for a medDay Pharmaceuticals clinical trial. He has received grant/research funding (paid directly to Institution): Biogen, Genentech, Department of Defense (USA), National MS Society, Patient Centered Outcomes Research Institute.
Patient consent for publication Obtained.
Provenance and peer review Not commissioned. Externally peer reviewed by Neil Robertson, Cardiff, UK.
Read the full text or download the PDF:
Other content recommended for you
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- Optic neuritis with potential for poor outcome
- Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
- Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
- Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up
- Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography
- Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein
- Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy